Anika Therapeutics
ANIK • NASDAQ
Anika Therapeutics is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Stephen D. Griffin, with a market cap of $191.4M.
CEOStephen D. Griffin
Next Earnings
Upcoming earnings announcement for Anika Therapeutics
Date
Friday, May 8, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.08
Revenue Estimate
$28.1M
Earnings History
Past 12 earnings reports for Anika Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | $0.31Est: -$0.06 | +616.7% | $30.6MEst: $28.9M | +6.0% | — |
| Nov 5, 2025 | Q3 2025 | $0.04Est: -$0.06 | +166.7% | $27.8MEst: $27.8M | 0.0% |  10-Q |
| Jul 30, 2025 | Q2 2025 | -$0.13Est: -$0.21 | +38.1% | $28.2MEst: $27.0M | +4.4% | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.06Est: $0.09 | -166.7% | $26.2MEst: $28.1M | -6.7% | 10-Q |
| Mar 12, 2025 | Q4 2024 | -$0.03Est: $0.09 | -133.3% | $30.6MEst: $29.0M | +5.5% | 10-K |
| Oct 31, 2024 | Q3 2024 | -$0.25Est: -$0.01 | -2400.0% | $38.8MEst: $42.1M | -7.9% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $0.17Est: $0.05 | +240.0% | $41.9MEst: $42.1M | -0.4% | 10-Q |
| May 8, 2024 | Q1 2024 | $0.09Est: -$0.19 | +147.4% | $40.5MEst: $39.1M | +3.5% | 10-Q |
| Mar 13, 2024 | Q4 2023 | $0.05Est: -$0.26 | +119.2% | $43.0MEst: $41.4M | +3.8% | 10-K/A |
| Nov 2, 2023 | Q3 2023 | $0.00Est: -$0.37 | +100.0% | $41.5MEst: $38.3M | +8.3% | — |
| Aug 8, 2023 | Q2 2023 | $0.06Est: -$0.27 | +122.2% | $44.3MEst: $40.6M | +9.2% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.36Est: -$0.30 | -20.0% | $37.9MEst: $37.3M | +1.7% | — |